Filed: 5/15/2024ACC: 0000950123-24-005559
📋 What this filing means
BLUE OWL CAPITAL HOLDINGS LP filed this quarterly 13F‑HR report disclosing 45 equity positions with a total reported market value of $500.58M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
45
Positions
$500.58M
Total AUM (reported)
49.98M
Total Shares
Allocation by class
COM$359.85M71.9%
COM CL A$62.85M12.6%
COM SER A$39.60M7.9%
SHS$11.63M2.3%
CL A$9.21M1.8%
CLASS A ORD$5.02M1.0%
COMMON STOCK$3.85M0.8%
Portfolio Concentration
Top 3$148.59M29.7%
4–10$200.56M40.1%
11–25$117.92M23.6%
Rest$33.51M6.7%
Top 3 weight
29.7%
Top 10 weight
69.7%
Voting Authority Distribution
Total shares with voting rights: 0.00
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other45
Dominant voting typeNone · 0.0% of voting shares
Institutional Holdings45
Rows:
ROBINHOOD MKTS INC
DFNDShares4.24M
TypeSH
Market value$53.98M
10.78%
Sole
0.00
Shared
0.00
None
0.00
CULLINAN ONCOLOGY INC
DFNDShares2.92M
TypeSH
Market value$49.84M
9.96%
Sole
0.00
Shared
0.00
None
0.00
PLIANT THERAPEUTICS INC
DFNDShares3M
TypeSH
Market value$44.76M
8.94%
Sole
0.00
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
DFNDShares2.46M
TypeSH
Market value$41.72M
8.33%
Sole
0.00
Shared
0.00
None
0.00
TOURMALINE BIO INC
DFNDShares1.45M
TypeSH
Market value$31.99M
6.39%
Sole
0.00
Shared
0.00
None
0.00
BLUE OWL CAPITAL CORPORATION
DFNDShares2.05M
TypeSH
Market value$31.45M
6.28%
Sole
0.00
Shared
0.00
None
0.00
KLAVIYO INC
DFNDShares1.20M
TypeSH
Market value$30.53M
6.10%
Sole
0.00
Shared
0.00
None
0.00
LARIMAR THERAPEUTICS INC
DFNDShares3.99M
TypeSH
Market value$30.32M
6.06%
Sole
0.00
Shared
0.00
None
0.00
ACELYRIN INC
DFNDShares2.83M
TypeSH
Market value$19.08M
3.81%
Sole
0.00
Shared
0.00
None
0.00
EVERCOMMERCE INC
DFNDShares1.64M
TypeSH
Market value$15.47M
3.09%
Sole
0.00
Shared
0.00
None
0.00
REPARE THERAPEUTICS INC
DFNDShares3.12M
TypeSH
Market value$14.71M
2.94%
Sole
0.00
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
DFNDShares268.24K
TypeSH
Market value$12.52M
2.50%
Sole
0.00
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
DFNDShares172.63K
TypeSH
Market value$11.43M
2.28%
Sole
0.00
Shared
0.00
None
0.00
INOZYME PHARMA INC
DFNDShares1.27M
TypeSH
Market value$9.73M
1.94%
Sole
0.00
Shared
0.00
None
0.00
DISC MEDICINE INC
DFNDShares155.26K
TypeSH
Market value$9.67M
1.93%
Sole
0.00
Shared
0.00
None
0.00
SAGIMET BIOSCIENCES INC
DFNDShares1.67M
TypeSH
Market value$9.07M
1.81%
Sole
0.00
Shared
0.00
None
0.00
TOAST INC
DFNDShares322.58K
TypeSH
Market value$8.04M
1.61%
Sole
0.00
Shared
0.00
None
0.00
E2OPEN PARENT HOLDINGS INC
DFNDShares1.65M
TypeSH
Market value$7.33M
1.46%
Sole
0.00
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
DFNDShares541.08K
TypeSH
Market value$6.99M
1.40%
Sole
0.00
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
DFNDShares2.83M
TypeSH
Market value$5.60M
1.12%
Sole
0.00
Shared
0.00
None
0.00
IKENA ONCOLOGY INC
DFNDShares3.89M
TypeSH
Market value$5.53M
1.10%
Sole
0.00
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares100K
TypeSH
Market value$5.02M
1.00%
Sole
0.00
Shared
0.00
None
0.00
DELL TECHNOLOGIES INC
DFNDShares41.24K
TypeSH
Market value$4.71M
0.94%
Sole
0.00
Shared
0.00
None
0.00
OMEGA THERAPEUTICS INC
DFNDShares1.06M
TypeSH
Market value$3.85M
0.77%
Sole
0.00
Shared
0.00
None
0.00
AQUESTIVE THERAPEUTICS INC
DFNDShares875K
TypeSH
Market value$3.73M
0.74%
Sole
0.00
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ROBINHOOD MKTS INCDFND | COM CL A | 4.24M | SH | $53.98M 10.78% | 0.00 | 0.00 | 0.00 |
CULLINAN ONCOLOGY INCDFND | COM | 2.92M | SH | $49.84M 9.96% | 0.00 | 0.00 | 0.00 |
PLIANT THERAPEUTICS INCDFND | COM | 3M | SH | $44.76M 8.94% | 0.00 | 0.00 | 0.00 |
ENGENE HOLDINGS INCDFND | COM | 2.46M | SH | $41.72M 8.33% | 0.00 | 0.00 | 0.00 |
TOURMALINE BIO INCDFND | COM | 1.45M | SH | $31.99M 6.39% | 0.00 | 0.00 | 0.00 |
BLUE OWL CAPITAL CORPORATIONDFND | COM | 2.05M | SH | $31.45M 6.28% | 0.00 | 0.00 | 0.00 |
KLAVIYO INCDFND | COM SER A | 1.20M | SH | $30.53M 6.10% | 0.00 | 0.00 | 0.00 |
LARIMAR THERAPEUTICS INCDFND | COM | 3.99M | SH | $30.32M 6.06% | 0.00 | 0.00 | 0.00 |
ACELYRIN INCDFND | COM | 2.83M | SH | $19.08M 3.81% | 0.00 | 0.00 | 0.00 |
EVERCOMMERCE INCDFND | COM | 1.64M | SH | $15.47M 3.09% | 0.00 | 0.00 | 0.00 |
REPARE THERAPEUTICS INCDFND | COM | 3.12M | SH | $14.71M 2.94% | 0.00 | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INDFND | COM | 268.24K | SH | $12.52M 2.50% | 0.00 | 0.00 | 0.00 |
KEROS THERAPEUTICS INCDFND | COM | 172.63K | SH | $11.43M 2.28% | 0.00 | 0.00 | 0.00 |
INOZYME PHARMA INCDFND | COM | 1.27M | SH | $9.73M 1.94% | 0.00 | 0.00 | 0.00 |
DISC MEDICINE INCDFND | COM | 155.26K | SH | $9.67M 1.93% | 0.00 | 0.00 | 0.00 |
SAGIMET BIOSCIENCES INCDFND | COM SER A | 1.67M | SH | $9.07M 1.81% | 0.00 | 0.00 | 0.00 |
TOAST INCDFND | CL A | 322.58K | SH | $8.04M 1.61% | 0.00 | 0.00 | 0.00 |
E2OPEN PARENT HOLDINGS INCDFND | COM CL A | 1.65M | SH | $7.33M 1.46% | 0.00 | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCDFND | COM | 541.08K | SH | $6.99M 1.40% | 0.00 | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCDFND | COM | 2.83M | SH | $5.60M 1.12% | 0.00 | 0.00 | 0.00 |
IKENA ONCOLOGY INCDFND | COM | 3.89M | SH | $5.53M 1.10% | 0.00 | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 100K | SH | $5.02M 1.00% | 0.00 | 0.00 | 0.00 |
DELL TECHNOLOGIES INCDFND | SHS | 41.24K | SH | $4.71M 0.94% | 0.00 | 0.00 | 0.00 |
OMEGA THERAPEUTICS INCDFND | COMMON STOCK | 1.06M | SH | $3.85M 0.77% | 0.00 | 0.00 | 0.00 |
AQUESTIVE THERAPEUTICS INCDFND | COM | 875K | SH | $3.73M 0.74% | 0.00 | 0.00 | 0.00 |
Page 1 of 2